Joanne L Billings

SEATTLE CHILDREN'S HOSPITAL, CYSTIC FIBROSIS FOUNDATION

1/1/20 → 12/31/22

Project: Research project

A Phase 3, Open-label Study Evaluating the Long-term Safety of VX-445 Combination Therapy in Subjects With Cystic Fibrosis

7/30/19 → 12/31/22

Project: Research project

A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of VX-445 Combination Therapy in Subjects With Cystic Fibrosis Who Are Heterozygous for the F508del Mutation and a Gating or Residual Function Mutation (F/G and F/RF Genotypes)

7/30/19 → 12/31/22

Project: Research project

A Phase 2, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of VX-561 in Subjects aged 18 Years and Olderwith Cystic Fibrosis

6/1/19 → 7/31/22

Project: Research project

A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safetyof 445 Combination Therapy in Subjects With Cystic Fibrosis Who Are Heterozygous for the F508delMutation and a Gating or Residual Function Mutation (F/G and F/RF Ge

5/23/19 → 1/1/21

Project: Research project

Sexual and Reproductive Health in Adult Women with Cystic Fibrosis

UNIVERSITY OF PITTSBURGH, CYSTIC FIBROSIS FOUNDATION

4/1/19 → 3/31/20

Project: Research project

A Phase 2, Randomized, Double-blind, Controlled Study to Evaluate the Safety and Efficacyof VX-121 Combination Therapy in Subjects Aged 18 Years and Older With Cystic Fibrosis

3/21/19 → 1/1/21

Project: Research project

APPLAUD: A double-blinded, randomized, placebo-controlled, Phase 2 study of the efficacy and safety ofLAU-7B in the treatment of cystic fibrosis through correction of the AA/DHA imbalance

LAURENT PHARMACEUTICALS INC

11/1/18 → 10/31/21

Project: Research project

PTI-428-06: A Phase 2, Multicenter, Randomized, Double-Blind,Placebo Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics, and Effect of PTI-428 inSubjects with Cystic Fibrosis

PROTEOSTASIS THERAPEUTICS, INC.

9/28/18 → 1/1/20

Project: Research project

PTI-808-01: A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PTI-808 inHealthy Adult Subjects and in Adults with Cystic Fibrosis

PROTEOSTASIS THERAPEUTICS, INC.

7/1/18 → 1/1/21

Project: Research project

VX17-659-105: A Phase 3, Open-label Study Evaluating the

5/9/18 → 5/1/21

Project: Research project

VX17-659-102: A Phase 3, Randomized, Double-blind, Contr

4/12/18 → 3/12/20

Project: Research project

VX16-809-120: A Post-approval Observational Study to Evaluate the Long-term Effectiveness and Safety ofOrkambi in US Patients Who Completed Study VX12-809-105 Part A

NIH NAT'L CTR FOR ADVANCING TRAN SCIENCE

4/1/18 → 12/31/19

Project: Research project

University of Minnesota Clinical and Translational Science Institute (UMN CTSI)

Blazar, B. R., AbuSalah, A. M., Adam, T. J., Aliferis, MD, PhD, C., Allen, J., Beckman, K. B., Billings, J. L., Bloomfield, H. E., Bornsztein, B., Brearley, A. M., Call, K. T., Chi, C., Clancy, T. R., Connett, J. E., Daniels, B. S., Eder, M., El-Fakahany, E. E., Fischer, G., Fulkerson, J., Garwood, M., Georgopoulos, A. P., Guan, W., Henderson, J. N., Hodges, J. S., Ingbar, D. H., Jones-Webb, R. J., Jordan, C., Karypis, G., Knights, D., Kumar, V., LeBien, T. W., Lim, K. O., Ma, S., Melton-Meaux, G. B., Myers, C. L., Neuhauser, C., Oakes, M., Okuyemi, K., Pakhomov, S. V., Panoskaltsis-Mortari, A., Pieczkiewicz, D. S., Raymond, N. C., Riggs, S., Rudser, K., Ruggles, S., Schacker, T. W., Schleiss, M. R., Shekhar, S., Shen, S., Simon, G. J., Ugurbil, K., Vock, D. M., Volkov, B. B., Wang, J., Warren, R., Weber-Main, A. M., Weisdorf, D. J., Wolf, S. M., Zellmer-Bruhn, M. E. & Zhang, R.

3/30/18 → 11/17/23

Project: Research project

Novartis CQBW276X2201: A randomized, double blind, place

NOVARTIS PHARMACEUTICALS CORPORATION

6/1/17 → 1/11/20

Project: Research project

VX15-440-101: A Phase 2, Randomized, Double-blind, Contr

11/6/16 → 1/1/20

Project: Research project

GS-US-404-1808: A Phase 2b, Dose-Ranging Study of the Ef

11/1/16 → 11/1/20

Project: Research project

Nurse Practitioner Additional Research Coordinator(ARC)

1/1/16 → 3/31/23

Project: Research project

VX15-371-101: A Phase 2a, Randomized, Double-blind

12/15/15 → 5/31/18

Project: Research project

Multicenter Clinical Phenotyping of Cystic Fibrosis

UNIVERSITY OF CALIFORNIA SAN DIEGO, GILEAD SCIENCES, INC.

12/1/15 → 11/13/17

Project: Research project

VX14-661-110: A Phase 3, Open-label, Rollover Study to E

Billings, J. L. & Laguna, T.

10/5/15 → 10/5/18

Project: Research project

N91115-2CF-05 (SNO-6): A Phase 2, Randomized, Double-Bli

NIVALIS THERAPEUTICS, INC.

9/15/15 → 12/31/16

Project: Research project

A Phase 3 Efficacy and Safety Study of Ataluren (PTC124)

PTC THERAPEUTICS, INC.

3/20/15 → 3/20/16

Project: Research project

A Phase 1b, Randomized, Double-Blind, Placebo-Controlled

NIVALIS THERAPEUTICS, INC.

1/31/15 → 1/31/17

Project: Research project

University of Minnesota Additional Research Coordinator

1/1/15 → 3/31/22

Project: Research project

2015 Therapeutics Development Center Spring Meeting

1/1/15 → 6/30/15

Project: Research project

DMP-CF-303: Long Term Administration of Inhaled Mannitol

PHARMAXIS LTD

10/1/14 → 10/1/17

Project: Research project

A Two-Part Multicenter Prospective Longitudinal Study

SEATTLE CHILDREN'S HOSPITAL, CYSTIC FIBROSIS FOUNDATION

7/1/14 → 1/31/19

Project: Research project

VX12-809-105: A Phase 3, Rollover Study to Evaluate

12/6/13 → 12/6/16

Project: Research project

The EPIC Observational Study: Longitudinal Assessment of

SEATTLE CHILDREN'S HOSPITAL, CYSTIC FIBROSIS FOUNDATION

9/1/13 → 10/1/20

Project: Research project

A Phase 2, Multi-Center, Randomized, Placebo-Controlled

SEATTLE CHILDREN'S HOSPITAL, NIH NAT'L HEART, LUNG, AND BLOOD INSTITU

9/1/13 → 6/30/18

Project: Research project

A Phase 3, Randomized, Double Blind, Placebo Controlled,

1/31/13 → 1/31/16

Project: Research project

A Phase 1b, Randomized, Double-Blind, Placebo-Controlled

NIVALIS THERAPEUTICS, INC.

1/15/13 → 1/15/15

Project: Research project

Genetic Epidemiology of COPD

NATIONAL JEWISH HEALTH, NIH NAT'L HEART, LUNG, AND BLOOD INSTITU

1/1/13 → 7/31/23

Project: Research project

KB001A-05, A Phase 2, Randomized, Double-blind, Placebo-

KaloBios Pharmaceuticals, Inc.

11/30/12 → 6/30/15

Project: Research project

A Long-Term Prospective Observational Study of the Incid

CYSTIC FIBROSIS FOUNDATION, ABBOTT LABORATORIES

6/1/12 → 6/1/23

Project: Research project

Prospective Observational Study to Evaluate Biomarkers

Billings, J. L. & Dunitz, J. M.

FOUNDATION FOR THE NAT'L INST. OF HEALTH

4/1/12 → 6/30/16

Project: Research project

A Phase 3, Open-Label, Randomized Trial To Evaluate The

3/15/12 → 3/14/13

Project: Research project

G551D Observational Study

SEATTLE CHILDREN'S HOSPITAL, CYSTIC FIBROSIS FOUNDATION

9/1/11 → 12/31/20

Project: Research project

Early Intervention in Cystic Fibrosis Exacerbation (eICE

SEATTLE CHILDREN'S HOSPITAL, CYSTIC FIBROSIS FOUNDATION

8/1/11 → 2/28/16

Project: Research project

A Prospective, 5-year Registry Study to Monitor

7/1/11 → 7/1/17

Project: Research project

A Phase 3, Open-Label, Randomized Trial To Evaluate The

3/15/11 → 6/1/13

Project: Research project

A PHASE 3, MULTI-CENTER, MULTINATIONAL, RANDOMIZED, DOUB

2/10/11 → 12/31/12

Project: Research project

A Phase 3, Randomized, Double-Blind, Placebo-Controlled,

9/16/09 → 9/9/12

Project: Research project

Translational Therapeutics Development Center

Billings, J. L. & Regelmann, W. E.

1/1/09 → 3/31/23

Project: Research project

A Double-Blind, Multicenter, Multinational, Randomized,

10/1/08 → 9/30/09

Project: Research project

A Phase 2, Multi-Center, Randomized, Double-Blind, Place

9/1/08 → 8/31/10

Project: Research project

Expanded Access Program for Aztreonam Lysine

1/15/08 → 12/31/10

Project: Research project

A Phase I/II Randomized, Double-Blind, Placebo-Controlle